Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    savita thakur thakur
    savita thakur thakur
      • Home
      • savita thakur thakur

      Articles By : savita thakur thakur

      BD India Recognized Amongst the Best Healthcare Brands in the Country

      BD India Recognized Amongst the Best Healthcare Brands in the Country

      savita thakur thakur3 July 2016 12:51 PM IST
      New Delh : BD India was awarded the Economic Times Best Healthcare Brand 2016 under the Medical Devices and Equipment segment. The award was presented...
      UK drugs regulator to halt approvals for Indian clinical trials firm

      UK drugs regulator to halt approvals for Indian clinical trials firm

      savita thakur thakur2 July 2016 3:56 PM IST
      Mumbai : The UK's healthcare regulator has decided to suspend marketing approval for a widely used antibiotic that had won clearance based on clinical...
      AstraZeneca sells two dermatology drug rights to LEO Pharma

      AstraZeneca sells two dermatology drug rights to LEO Pharma

      savita thakur thakur2 July 2016 3:55 PM IST
      British drugmaker AstraZeneca Plc said it sold the rights to develop an experimental mid-stage drug to treat a topic dermatitis to privately-held LEO...
      FDA approves implantable device that changes the shape of the cornea to correct near vision

      FDA approves implantable device that changes the shape of the cornea to correct near vision

      savita thakur thakur2 July 2016 3:55 PM IST
      The U.S. Food and Drug Administration approved the Raindrop Near Vision Inlay, a device implanted in the cornea (the clear, front surface) of one eye...
      Shire says ADHD drug meets main goal of study

      Shire says ADHD drug meets main goal of study

      savita thakur thakur2 July 2016 3:55 PM IST
      Irish drugmaker Shire Plc said a study testing an experimental drug to treat attention-deficit disorder met the main goal, bringing the drug one step...
      Lipocine says FDA does not approve its testosterone drug

      Lipocine says FDA does not approve its testosterone drug

      savita thakur thakur1 July 2016 1:58 PM IST
      Lipocine Inc said its oral testosterone replacement product did not get the approval in the United States, sending the drugmaker's shares down 52 pct...
      Consumer Forum asks insurance company to Rs 1.7 lakh to woman

      Consumer Forum asks insurance company to Rs 1.7 lakh to woman

      savita thakur thakur1 July 2016 1:58 PM IST
      The district consumer forum has directed an insurance company to pay close to Rs two lakh to a woman suffering from brain tumour, after she was denied...
      Limited protection of GSKs malaria vaccine dwindles in 7 years

      Limited protection of GSK's malaria vaccine dwindles in 7 years

      savita thakur thakur1 July 2016 1:44 PM IST
      London : The world's first malaria vaccine, developed by GlaxoSmithKline, provides some protection after three doses but its effect dwindles to...
      Suven Life Sciences gets patent for neuro-degenerative drug

      Suven Life Sciences gets patent for neuro-degenerative drug

      savita thakur thakur30 Jun 2016 3:08 PM IST
      New Delhi : Drug firm Suven Life Sciences has been granted a patent from Europe and two product patents from Eurasia for a drug used in the treatment...
      Piramal Enterprises raises Rs 105 crore via NCDs

      Piramal Enterprises raises Rs 105 crore via NCDs

      savita thakur thakur30 Jun 2016 2:57 PM IST
      New Delhi : Piramal Enterprises has raised Rs 105 crore in the second tranche through issue of debentures as part of its overall plan to mop up Rs...
      US panel backs claim that  Jardiance cuts cardiac death

      US panel backs claim that Jardiance cuts cardiac death

      savita thakur thakur30 Jun 2016 2:57 PM IST
      Eli Lilly & Co and Boehringer Ingelheim should be allowed to claim that their diabetes drug Jardiance cuts the risk of cardiovascular death, an...
      Dr Reddys completes Rs 1,569.41 cr share buyback

      Dr Reddy's completes Rs 1,569.41 cr share buyback

      savita thakur thakur29 Jun 2016 1:39 PM IST
      New Delhi : Drug major Dr Reddy's Laboratories said it has bought back nearly 51 lakh shares for Rs 1,569.41 crore as part of a 'share buyback' offer...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok